Elaborative gene microarray studies of drug (Methotrexate, Cisplatin, Doxorubicin, Vincristine, Topotecan and Paclitaxel) resistant ovarian cancer cells has identified dysregulation of several NRF2 regulated SLC transporter genes after resistance development. Here, NFE2L2 is linked to ovarian cancer.